Eye Care

Medicated ring shows better adherence rate and decreased eye pressure in patients with glaucoma or ocular hypertension.

Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.

Metformin use is associated with a reduced risk of glaucoma development among diabetics.

Glaucoma patients typically have ever-changing drug therapy regimens involving multiple eye drop products.

The FDA is reviewing a novel treatment for patients with open angle glaucoma or ocular hypertension.

Early detection and treatment are key to protecting eyesight.

Early detection and treatment are key to protecting eyesight.

This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.

Switching patients with glaucoma to generic medications can improve their adherence to ophthalmic drug therapies, according to researchers from the University of Michigan Kellogg Eye Center and College of Pharmacy.

Latanoprost eye drops may significantly reduce the risk of vision loss in patients with glaucoma.

Latanoprostene bunod (Vesneo) demonstrated noninferiority to timolol maleate (Timoptic 5%) in pivotal Phase 3 studies.

Selenium and vitamin E supplementation will not prevent cataracts in men, a new study suggests.

Comprehensive ophthalmologists underestimated the likelihood that optic discs had signs of glaucoma almost one-fourth of the time compared with judgments by glaucoma specialists, according to the results of a new study.

Although clinical trials have indicated that intraocular pressure-lowering medications are effective in patients with open-angle glaucoma, new research suggests that the medications may not be as effective in real-world settings.

A lack of warning signs can delay detection and treatment of glaucoma.

Insomnia is one of the most prevalent patient complaints, ranking third after headaches and the common cold.

Based on a review of studies on the risks and benefits of early screening and treatment for glaucoma, the United States Preventive Services Task Force concluded that it could not recommend for or against screening for asymptomatic adults.

Of the 50 million people in the United States diagnosed with some form of arthritis, 300,000 are children, whose symptoms are similar to those seen in adults with the condition.

Many glaucoma patients take vitamin supplements as part of their therapy, but a new study finds little evidence that they help prevent the condition from developing.

More than a dozen states now allow medical marijuana as a treatment for glaucoma, although medical opinions of its suitability are mixed.

Based on a review of almost 100 trials and studies, researchers determined that the available evidence was too limited to support or oppose primary open-angle glaucoma screening in adults.

An international consortium of researchers has discovered 3 genetic anomalies associated with primary angle closure glaucoma (PACG), which may help lead to the development of new treatments.

Supplements for age-related eye disease may be appropriate for some older patients.

The recently approved stent is implanted in conjunction with cataract surgery and is designed to decrease intraocular pressure.